SE453537B - Sett att framstella blandningar innehallande partiklar av lipoidlosliga substanser och vid dessa bundna biologiskt aktiva substanser - Google Patents

Sett att framstella blandningar innehallande partiklar av lipoidlosliga substanser och vid dessa bundna biologiskt aktiva substanser

Info

Publication number
SE453537B
SE453537B SE8009068A SE8009068A SE453537B SE 453537 B SE453537 B SE 453537B SE 8009068 A SE8009068 A SE 8009068A SE 8009068 A SE8009068 A SE 8009068A SE 453537 B SE453537 B SE 453537B
Authority
SE
Sweden
Prior art keywords
particles
biologically active
lipoid
substances
solution
Prior art date
Application number
SE8009068A
Other languages
English (en)
Swedish (sv)
Other versions
SE8009068L (sv
Inventor
Z Riedl
L Sztankov
I Horvath
Original Assignee
Human Oltoanyagtermelo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Oltoanyagtermelo filed Critical Human Oltoanyagtermelo
Publication of SE8009068L publication Critical patent/SE8009068L/
Publication of SE453537B publication Critical patent/SE453537B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8009068A 1979-12-27 1980-12-22 Sett att framstella blandningar innehallande partiklar av lipoidlosliga substanser och vid dessa bundna biologiskt aktiva substanser SE453537B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79HU299A HU184141B (en) 1979-12-27 1979-12-27 Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof

Publications (2)

Publication Number Publication Date
SE8009068L SE8009068L (sv) 1981-06-28
SE453537B true SE453537B (sv) 1988-02-08

Family

ID=10997378

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8009068A SE453537B (sv) 1979-12-27 1980-12-22 Sett att framstella blandningar innehallande partiklar av lipoidlosliga substanser och vid dessa bundna biologiskt aktiva substanser

Country Status (21)

Country Link
US (1) US4396630A (cs)
JP (1) JPS57112334A (cs)
BE (1) BE886884A (cs)
CA (1) CA1165237A (cs)
CH (1) CH655246A5 (cs)
CS (1) CS241478B2 (cs)
DD (1) DD158738A5 (cs)
DE (1) DE3048815A1 (cs)
DK (1) DK160288C (cs)
ES (1) ES8201316A1 (cs)
FR (1) FR2472386B1 (cs)
GB (1) GB2066203B (cs)
HU (1) HU184141B (cs)
IT (1) IT1150073B (cs)
NL (1) NL8007041A (cs)
PL (1) PL228755A1 (cs)
PT (1) PT72261B (cs)
RO (1) RO81371A (cs)
SE (1) SE453537B (cs)
SU (1) SU1487802A3 (cs)
YU (1) YU44413B (cs)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4598051A (en) * 1980-03-12 1986-07-01 The Regents Of The University Of California Liposome conjugates and diagnostic methods therewith
US4806466A (en) * 1981-10-29 1989-02-21 The Regents Of The University Of California Cell agglutination reagent comprising conjugates of antibody covalently bound to liposomes
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
DD247570A3 (de) * 1983-01-14 1987-07-15 Univ Berlin Humboldt Vesikulaeres trenn-, fuell- und traegermaterial
US4515736A (en) * 1983-05-12 1985-05-07 The Regents Of The University Of California Method for encapsulating materials into liposomes
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US6090406A (en) * 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
US5916588A (en) * 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US4619904A (en) * 1984-10-29 1986-10-28 General Electric Company Agglutinating immunoassay using protein-coated liquid droplets
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
DE3584523D1 (de) * 1985-10-31 1991-11-28 Kv Pharm Co System zum freigeben von stoffen in der vagina.
US4790987A (en) * 1985-11-15 1988-12-13 Research Corporation Viral glycoprotein subunit vaccine
CA1338736C (fr) * 1986-12-05 1996-11-26 Roger Baurain Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
US4748024A (en) * 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
US5688519A (en) * 1987-04-06 1997-11-18 Leonard; Robert J. Flash-flow fused medicinal implants
WO1990001947A1 (en) * 1988-08-25 1990-03-08 The Liposome Company, Inc. Affinity associated vaccine
EP0374296B1 (en) * 1988-12-22 1995-02-01 Dade International Inc. Lipohaptens and use of carrier-bound lipohaptens in immunoassays
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
JPH07113641B2 (ja) * 1989-11-17 1995-12-06 積水化学工業株式会社 梅毒診断試薬の製造方法
NL9000207A (cs) * 1990-01-29 1991-08-16 Duphar Int Res
ATE185486T1 (de) * 1990-06-29 1999-10-15 Chiron Corp Liposomen enthaltende impfstoffzusammensetzungen
US5709879A (en) * 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
IE912535A1 (en) * 1990-07-27 1992-01-29 Res Dev Foundation Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens
WO1992004887A1 (fr) * 1990-09-25 1992-04-02 Kyowa Hakko Kogyo Co., Ltd. Production de lymphocites t cytotoxiques
US6048531A (en) * 1991-04-15 2000-04-11 Albany Medical College Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies
US5336507A (en) * 1992-12-11 1994-08-09 Sterling Winthrop Inc. Use of charged phospholipids to reduce nanoparticle aggregation
GB9320668D0 (en) * 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
AUPM500494A0 (en) * 1994-04-12 1994-05-05 Minister For Agriculture & Rural Affairs For The State Of New South Wales, The Composition for use in increasing mucosal immunity
SK7092003A3 (en) * 2000-11-09 2004-06-08 Neopharm Inc SN-38 lipid complexes and methods of use
WO2003030864A1 (en) * 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
WO2003075889A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections
WO2004035032A2 (en) * 2002-08-20 2004-04-29 Neopharm, Inc. Pharmaceutical formulations of camptothecine derivatives
US20060030578A1 (en) * 2002-08-20 2006-02-09 Neopharm, Inc. Pharmaceutically active lipid based formulation of irinotecan
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
DK1581236T3 (da) * 2002-10-29 2013-12-02 Insmed Inc Opretholdt afgivelse af antiinfektionsmidler
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
WO2006090816A1 (ja) * 2005-02-25 2006-08-31 Mie University リポソームワクチンの作製法
PL1962805T3 (pl) 2005-12-08 2017-01-31 Insmed Incorporated Kompozycje środków przeciwzapalnych oparte na lipidach do leczenia infekcji płucnych
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
PT2852391T (pt) 2012-05-21 2022-02-18 Insmed Inc Sistemas para tratamento de infeções pulmonares
RU2018135921A (ru) 2012-11-29 2019-02-05 Инсмед Инкорпорейтед Стабилизированные составы ванкомицина
MX376012B (es) 2014-05-15 2025-03-07 Insmed Inc Metodos para tratar infecciones pulmonares micobacterianas no tuberculosas.
JP7460534B2 (ja) 2018-03-30 2024-04-02 インスメッド インコーポレイテッド リポソーム医薬品の連続製造方法
US20210113467A1 (en) 2018-05-02 2021-04-22 Robert Worsham Methods for the manufacture of liposomal drug formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
JPS5126213A (ja) * 1974-08-21 1976-03-04 Tanabe Seiyaku Co Johoseibiryushiseizaino seiho
GB1564500A (en) * 1975-09-29 1980-04-10 Wellcome Found Biological preparations
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
IT1110989B (it) * 1979-01-19 1986-01-13 Erba Farmitalia Forme farmaceutiche costitutite da liposomi e procedimenti relativi
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
JPS55118415A (en) * 1979-02-28 1980-09-11 Pii Papahadojiyopo Dometoriosu Method of encapsulating biologically active substance in lipoid cell

Also Published As

Publication number Publication date
GB2066203B (en) 1984-01-11
SU1487802A3 (ru) 1989-06-15
US4396630A (en) 1983-08-02
YU329080A (en) 1984-04-30
HU184141B (en) 1984-07-30
DD158738A5 (de) 1983-02-02
JPH0314814B2 (cs) 1991-02-27
CS924680A2 (en) 1985-07-16
JPS57112334A (en) 1982-07-13
DE3048815A1 (de) 1981-09-10
RO81371B (ro) 1983-11-02
CA1165237A (en) 1984-04-10
IT8026950A0 (it) 1980-12-24
CH655246A5 (de) 1986-04-15
FR2472386B1 (cs) 1985-08-23
ES498048A0 (es) 1981-12-16
BE886884A (fr) 1981-06-29
IT1150073B (it) 1986-12-10
CS241478B2 (en) 1986-03-13
DK160288B (da) 1991-02-25
DK160288C (da) 1991-08-05
PT72261B (en) 1981-11-05
NL8007041A (nl) 1981-07-16
ES8201316A1 (es) 1981-12-16
RO81371A (ro) 1984-04-02
DK552280A (da) 1981-06-28
PT72261A (en) 1981-01-01
YU44413B (en) 1990-08-31
SE8009068L (sv) 1981-06-28
PL228755A1 (cs) 1982-02-15
FR2472386A1 (cs) 1981-07-03
GB2066203A (en) 1981-07-08

Similar Documents

Publication Publication Date Title
SE453537B (sv) Sett att framstella blandningar innehallande partiklar av lipoidlosliga substanser och vid dessa bundna biologiskt aktiva substanser
Schild et al. A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Proposals for an assay method for the haemagglutinin content of influenza vaccines
Choucroun Tubercle Bacillus Antigens, biological properties of two substances isolated from paraffin oil extract of dead tubercle bacilli
DE60121136T2 (de) Proteasom-influenzavirus-impfstoffzusammensetzung
CN105920599A (zh) 以阳离子脂质体dotap为佐剂的疫苗及其制备方法
US4816253A (en) Novel mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent
Alexander et al. Production of types a, b, c, d, e and f H. influenzae antibody for diagnostic and therapeutic purposes
Zollinger et al. Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide
CA1337047C (en) Gamma inulin compositions
US4567041A (en) Mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent
Mountain Antibody production by spleen in vitro: I. Influence of cortisone and other chemicals
RU2240822C2 (ru) Способ получения противотуляремийной гипериммунной сыворотки и способ получения диагностикума эритроцитарного туляремийного иммуноглобулинового сухого
Baer et al. The immunology and chemistry of tuberculin: I. The isolation of dialyzable and nondialyzable tuberculin-active components from unheated BCG culture filtrates
CN108948192B (zh) 豚鼠免疫制备的蒜氨酸抗体
SU1750689A1 (ru) Способ получени полисахаридно-белковой вакцины против NeISSeRIa меNINGIтIDIS серогруппы В
Vogel et al. A microflocculation test for trichinosis
RU2188036C1 (ru) Способ получения диагностикума эритроцитарного антигенного сапного
RU2120300C1 (ru) Способ получения эритроцитарного антигенного диагностикума
CN112316132B (zh) 一种姜黄素纳米脂质体佐剂及其制备方法
RU2062111C1 (ru) Способ получения диагностикума эритроцитарного сыпнотифозного антигенного сухого
US3183161A (en) Aqueous resuspension vaccine product of aluminum phosphate-adsorbed poliomyelitis virus antigen, and production process
SU1171038A1 (ru) Способ диагностики туберкулеза
RU2731521C1 (ru) Способ диагностики радиационных поражений организма и способ получения противолучевого антительного бентонитового препарата для диагностики радиационных поражений организма
RU2111013C1 (ru) Способ получения антител к арбовирусам комплекса калифорнийского энцефалита и батаи
Shkurhan The role of fungal lipids in the hypersensitive response

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8009068-1

Effective date: 19920704

Format of ref document f/p: F